{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:53:01Z","timestamp":1759683181173},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,6,10]],"date-time":"2008-06-10T00:00:00Z","timestamp":1213056000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s12017-008-8041-2","type":"journal-article","created":{"date-parts":[[2008,6,9]],"date-time":"2008-06-09T14:03:02Z","timestamp":1213020182000},"page":"362-367","source":"Crossref","is-referenced-by-count":19,"title":["Functional Polymorphism of the Human Multidrug Resistance Gene (MDR1) and Polydipsia\u2013Hyponatremia in Schizophrenia"],"prefix":"10.1007","volume":"10","author":[{"given":"Takahiro","family":"Shinkai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Fukunaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,10]]},"reference":[{"key":"8041_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0006-3223(91)90300-B","volume":"30","author":"RC Alexander","year":"1991","unstructured":"Alexander, R. C., Karp, B. I., Thompson, S., Khot, V., & Kirch, D. G. (1991). A double blind, placebo-controlled trial of demeclocycline treatment of polydipsia\u2013hyponatremia in chronically psychotic patients. Biological Psychiatry, 30, 417\u2013420.","journal-title":"Biological Psychiatry"},{"key":"8041_CR2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","volume":"39","author":"SV Ambudkar","year":"1999","unstructured":"Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999). Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annual Review of Pharmacology and Toxicology, 39, 361\u2013398.","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"8041_CR3","first-page":"527","volume":"20","author":"F Assal","year":"1994","unstructured":"Assal, F., & Chauchot, F. (1994). Hyponatremia of therapeutic origin. Apropos of a case. Encephale, 20, 527\u2013529.","journal-title":"Apropos of a case. Encephale"},{"key":"8041_CR4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0024-3205(02)01680-6","volume":"71","author":"DW Boulton","year":"2002","unstructured":"Boulton, D. W., DeVane, C. L., Liston, H. L., & Markowitz, J. S. (2002). In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sciences, 71, 163\u2013169.","journal-title":"Life Sciences"},{"key":"8041_CR5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychires.2006.10.002","volume":"42","author":"N Bozina","year":"2008","unstructured":"Bozina, N., Kuzman, M. R., Medved, V., Jovanovic, N., Sertic, J., & Hotujac, L. (2008). Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients. Journal of Psychiatric Research, 42, 89\u201397.","journal-title":"Journal of Psychiatric Research"},{"key":"8041_CR6","doi-asserted-by":"crossref","unstructured":"Campa, D., Gioia, A., Tomei, A., Poli, P., & Barale, R. (2008). Association of ABCB1\/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clinical Pharmacology & Therapeutics, 83, 559\u2013566.","DOI":"10.1038\/sj.clpt.6100385"},{"key":"8041_CR7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0006-3223(94)90008-6","volume":"35","author":"J Leon de","year":"1994","unstructured":"de Leon, J., Verghese, C., Tracy, J. I., Josiassen, R. C., & Simpson, G. M. (1994). Polydipsia and water intoxication in psychiatric patients: A review of the epidemiological literature. Biological Psychiatry, 35, 408\u2013419.","journal-title":"Biological Psychiatry"},{"key":"8041_CR8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/hup.720","volume":"20","author":"TB Ejsing","year":"2005","unstructured":"Ejsing, T. B., Pedersen, A. D., & Linnet, K. (2005). P-glycoprotein interaction with risperidone and 9-OH-risperidone studied in vitro, in knock-out mice and in drug-drug interaction experiments. Human Psychopharmacology, 20, 493\u2013500.","journal-title":"Hum. Psychopharmacol."},{"key":"8041_CR9","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1136\/bmj.291.6509.1594","volume":"291","author":"IN Ferrier","year":"1985","unstructured":"Ferrier, I. N. (1985). Water intoxication in patients with psychiatric illness. British Medical Journal, 291, 1594\u20131596.","journal-title":"Br. Med. J."},{"key":"8041_CR10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12017-007-8001-2","volume":"9","author":"Y Fukunaka","year":"2007","unstructured":"Fukunaka, Y., Shinkai, T., Hwang, R., et al. (2007). The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia\u2013hyponatremia in schizophrenia. Neuromolecular Medicine, 9, 292\u2013297.","journal-title":"Neuromolecular Med"},{"key":"8041_CR11","first-page":"114","volume":"6","author":"LS Godleski","year":"1988","unstructured":"Godleski, L. S., Vieweg, W. V., Barber, J. W., Glick, J. L., & Yank, G. R. (1988). Prevalence of polyuria among chronically psychotic men. Psychiatric Medicine, 6, 114\u2013120.","journal-title":"Psychiatr. Med"},{"key":"8041_CR12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0006-3223(94)90089-2","volume":"36","author":"DC Henderson","year":"1994","unstructured":"Henderson, D. C., & Goff, D. C. (1994). Clozapine for polydipsia and hyponatremia in chronic schizophrenics. Biological Psychiatry, 36, 768\u2013770.","journal-title":"Biological Psychiatry"},{"key":"8041_CR13","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","volume":"97","author":"S Hoffmeyer","year":"2000","unstructured":"Hoffmeyer, S., Burk, O., von Richter, O., et al. (2000). Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proceedings of the National Academy of Sciences of the United States of America, 97, 3473\u20133478.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8041_CR14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mcp.2001.117412","volume":"70","author":"RB Kim","year":"2001","unstructured":"Kim, R. B., Leake, B. F., Choo, E. F., et al. (2001). Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clinical Pharmacology and Therapeutics, 70, 189\u2013199.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"8041_CR15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","volume":"315","author":"C Kimchi-Sarfaty","year":"2007","unstructured":"Kimchi-Sarfaty, C., Oh, J. M., Kim, I. W., et al. (2007). A \u201csilent\u201d polymorphism in the MDR1 gene changes substrate specificity. Science, 315, 525\u2013528.","journal-title":"Science"},{"key":"8041_CR16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2217\/14622416.8.8.1075","volume":"8","author":"AA Komar","year":"2007","unstructured":"Komar, A. A. (2007). Silent SNPs: Impact on gene function and phenotype. Pharmacogenomics, 8, 1075\u20131080.","journal-title":"Pharmacogenomics"},{"key":"8041_CR17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2133\/dmpk.20.391","volume":"20","author":"T Sakaeda","year":"2005","unstructured":"Sakaeda, T. (2005). MDR1 genotype-related pharmacokinetics: Fact or fiction? Drug Metabolism and Pharmacokinetics, 20, 391\u2013414.","journal-title":"Metab. Pharmacokinet"},{"key":"8041_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajmg.b.10066","volume":"119B","author":"T Shinkai","year":"2003","unstructured":"Shinkai, T., Ohmori, O., Hori, H., & Nakamura, J. (2003). Genetic approaches to polydipsia in schizophrenia: A preliminary report of a family study and an association study of an angiotensin-converting enzyme gene polymorphism. American Journal of Medical Genetics, 119B, 7\u201312.","journal-title":"American Journal of Medical Genetics"},{"key":"8041_CR19","first-page":"457","volume":"17","author":"E Silverstein","year":"1958","unstructured":"Silverstein, E., Sokoloff, L., Mickelesen, O., & Jay, G. E., Jr. (1958). Polyuria, polydipsia and hydronephrosis in inbred strain of mice. Federation Proceedings, 17, 457.","journal-title":"Fed. Proc"},{"key":"8041_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00002018-199512030-00006","volume":"12","author":"O Spigset","year":"1995","unstructured":"Spigset, O., & Hedenmalm, K. (1995). Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Safety, 12, 209\u2013225.","journal-title":"Drug Safety"},{"key":"8041_CR21","volume-title":"Seishinbunretsubyo no yakuri (Pharmacology in schizophrenia)","author":"M Toru","year":"1983","unstructured":"Toru, M. (1983). Seishinbunretsubyo no yakuri (pharmacology in schizophrenia). Tokyo: Chu-gai Iyakusha Co."},{"key":"8041_CR22","doi-asserted-by":"crossref","unstructured":"Turgut, G., Kurt, E., Sengul, C., et al. (in press). Association of MDR1 C3435T polymorphism with bipolar disorder in patients treated with valproic acid. Molecular Biology Reports.","DOI":"10.1007\/s11033-007-9206-z"},{"key":"8041_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1528-1157.1994.tb02930.x","volume":"35","author":"T Amelsvoort Van","year":"1994","unstructured":"Van Amelsvoort, T., Bakshi, R., Devaux, C. B., & Schwabe, S. (1994). Hyponatremia associated with carbamazepine and oxcarbazepine therapy: A review. Epilepsia, 35, 181\u2013188.","journal-title":"Epilepsia"},{"key":"8041_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-1781(85)90041-1","volume":"15","author":"WV Vieweg","year":"1985","unstructured":"Vieweg, W. V., Rowe, W. T., David, J. J., Curnow, R. T., & Spradlin, W. W. (1985). Patterns of urinary excretion among patients with self-induced water intoxication and psychosis. Psychiatry Research, 15, 71\u201379.","journal-title":"Psychiatry Research"},{"key":"8041_CR25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1461145704004390","volume":"7","author":"JS Wang","year":"2004","unstructured":"Wang, J. S., Ruan, Y., Taylor, R. M., Donovan, J. L., Markowitz, J. S., & DeVane, C. L. (2004). The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein. International Journal of Neuropsychopharmacology, 7, 415\u2013419.","journal-title":"Int. J. Neuropsychopharmacol"},{"key":"8041_CR26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pnpbp.2005.06.019","volume":"30","author":"N Yasui-Furukori","year":"2006","unstructured":"Yasui-Furukori, N., Saito, M., Nakagami, T., Kaneda, A., Tateishi, T., & Kaneko, S. (2006). Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: A preliminary study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 286\u2013291.","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-008-8041-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-008-8041-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-008-8041-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:49:04Z","timestamp":1559440144000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-008-8041-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["8041"],"URL":"https:\/\/doi.org\/10.1007\/s12017-008-8041-2","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,10]]}}}